Parkinson disease

Active Research Protocols

  1. 00-M-0085 – Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 3.0 Tesla MRI and Magnetoencephalography
  2. 01-M-0232 – Positron Emission Tomography (PET) Scanning in Dopamine Disorders: Parkinson's Disease and Schizophrenia
  3. 03-N-0004 – Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure
  4. 03-N-0164 – Evaluation and Treatment of Neurosurgical Disorders
  5. 06-HG-0055 – Functional Imaging in Subjects with Glucocerebrosidase Mutations
  6. 07-N-0137 РExpanding the Phenotype of the LRRK-2 Mutation in Individuals with History of Parkinson̥s Disease and their Relatives: a Prospective Study
  7. 08-M-0124 – Measurement of P-Glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography
  8. 09-N-0010 – Biomarkers of Risk of Parkinson Disease
  9. 09-N-0160 – Convection Enhanced Delivery of Muscimol to Study the Pathophysiology Underlying the Clinical Features of Parkinson's Disease
  10. 10-N-0009 – Physiological Investigations of Movement Disorders
  11. 10-N-0057 – The Influence of Sensory Stimuli on Gait Imagery in Patients with Freezing of Gait
  12. 10-N-0092 – Genetics of Motor Learning
  13. 11-N-0157 – Analysis of Visual-Motor Task Electrophysiological Activity During Deep Brain Stimulation for Treatment-Resistant Movement Disorders
  14. 11-N-0211 – Deep Brain Stimulation Surgery for Movement Disorders
  15. 12-H-0084 – Metabolic Phenotyping of Subjects with Mutations Associated with Hereditary Parkinson's Disease
  16. 12-N-0012 – Pilot Study of Bilateral Pedunculo-Pontine Nucleus (PPN) Deep Brain Stimulation for Patients with Parkinson Disease (PD) Who Have Persistent Gait Disturbance, Despite Bilateral Subthalamic Nucleus (STN) Deep Brain Stimulation
  17. 12-N-0031 – Imaging Biomarkers in Parkinson Disease
  18. 12-N-0137 – A Phase 1 Open-Label Dose Escalation Safety Study of Convection Enhanced Delivery (CED) of Adeno-Associated Virus Encoding Glial Cell Line-Derived Neurotrophic Factor (AAV2-GDNF) in Subjects with Advanced Parkinson's Disease
  19. 13-N-0115 – Neural Correlates of Cognitive Impairment in Parkinson Disease
  20. 13-N-0167 – A Longitudinal Study Assessing the Pathophysiology of Movement Disorders Utilizing the QMAT at Home Testing Device
  21. 91-M-0124 – Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 1.5 Tesla MRI
  22. 92-DC-0178 – Multimodal Studies of Language Production and Comprehension in Normal Volunteers and Patients with Neurologically-Based Language Impairments
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014